Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers

Francesco Greco, Jeffrey A Cadeddu, Inderbir S. Gill, Jihad H. Kaouk, Mesut Remzi, R. Houston Thompson, Fijs W B Van Leeuwen, Henk G. Van Der Poel, Paolo Fornara, Jens Rassweiler

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Context Molecular imaging (MI) entails the visualisation, characterisation, and measurement of biologic processes at the molecular and cellular levels in humans and other living systems. Translating this technology to interventions in real-time enables interventional MI/image-guided surgery, for example, by providing better detection of tumours and their dimensions. Objective To summarise and critically analyse the available evidence on image-guided surgery for genitourinary (GU) oncologic diseases. Evidence acquisition A comprehensive literature review was performed using PubMed and the Thomson Reuters Web of Science. In the free-text protocol, the following terms were applied: molecular imaging, genitourinary oncologic surgery, surgical navigation, image-guided surgery, and augmented reality. Review articles, editorials, commentaries, and letters to the editor were included if deemed to contain relevant information. We selected 79 articles according to the search strategy based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis criteria and the IDEAL method. Evidence synthesis MI techniques included optical imaging and fluorescent techniques, the augmented reality (AR) navigation system, magnetic resonance imaging spectroscopy, positron emission tomography, and single-photon emission computed tomography. Experimental studies on the AR navigation system were restricted to the detection and therapy of adrenal and renal malignancies and in the relatively infrequent cases of prostate cancer, whereas fluorescence techniques and optical imaging presented a wide application of intraoperative GU oncologic surgery. In most cases, image-guided surgery was shown to improve the surgical resectability of tumours. Conclusions Based on the evidence to date, image-guided surgery has promise in the near future for multiple GU malignancies. Further optimisation of targeted imaging agents, along with the integration of imaging modalities, is necessary to further enhance intraoperative GU oncologic surgery.

Original languageEnglish (US)
Pages (from-to)947-964
Number of pages18
JournalEuropean Urology
Volume65
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Urogenital Neoplasms
Computer-Assisted Surgery
Molecular Imaging
Optical Imaging
Neoplasms
Therapeutics
Single-Photon Emission-Computed Tomography
PubMed
Positron-Emission Tomography
Meta-Analysis
Prostatic Neoplasms
Magnetic Resonance Spectroscopy
Magnetic Resonance Imaging
Technology
Kidney

Keywords

  • Augmented reality
  • Genitourinary oncologic surgery
  • Image-guided surgery
  • Molecular imaging
  • Surgical navigation

ASJC Scopus subject areas

  • Urology

Cite this

Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. / Greco, Francesco; Cadeddu, Jeffrey A; Gill, Inderbir S.; Kaouk, Jihad H.; Remzi, Mesut; Thompson, R. Houston; Van Leeuwen, Fijs W B; Van Der Poel, Henk G.; Fornara, Paolo; Rassweiler, Jens.

In: European Urology, Vol. 65, No. 5, 2014, p. 947-964.

Research output: Contribution to journalArticle

Greco, F, Cadeddu, JA, Gill, IS, Kaouk, JH, Remzi, M, Thompson, RH, Van Leeuwen, FWB, Van Der Poel, HG, Fornara, P & Rassweiler, J 2014, 'Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers', European Urology, vol. 65, no. 5, pp. 947-964. https://doi.org/10.1016/j.eururo.2013.07.033
Greco, Francesco ; Cadeddu, Jeffrey A ; Gill, Inderbir S. ; Kaouk, Jihad H. ; Remzi, Mesut ; Thompson, R. Houston ; Van Leeuwen, Fijs W B ; Van Der Poel, Henk G. ; Fornara, Paolo ; Rassweiler, Jens. / Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. In: European Urology. 2014 ; Vol. 65, No. 5. pp. 947-964.
@article{9cb903afe6944ec584c105952bcd705e,
title = "Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers",
abstract = "Context Molecular imaging (MI) entails the visualisation, characterisation, and measurement of biologic processes at the molecular and cellular levels in humans and other living systems. Translating this technology to interventions in real-time enables interventional MI/image-guided surgery, for example, by providing better detection of tumours and their dimensions. Objective To summarise and critically analyse the available evidence on image-guided surgery for genitourinary (GU) oncologic diseases. Evidence acquisition A comprehensive literature review was performed using PubMed and the Thomson Reuters Web of Science. In the free-text protocol, the following terms were applied: molecular imaging, genitourinary oncologic surgery, surgical navigation, image-guided surgery, and augmented reality. Review articles, editorials, commentaries, and letters to the editor were included if deemed to contain relevant information. We selected 79 articles according to the search strategy based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis criteria and the IDEAL method. Evidence synthesis MI techniques included optical imaging and fluorescent techniques, the augmented reality (AR) navigation system, magnetic resonance imaging spectroscopy, positron emission tomography, and single-photon emission computed tomography. Experimental studies on the AR navigation system were restricted to the detection and therapy of adrenal and renal malignancies and in the relatively infrequent cases of prostate cancer, whereas fluorescence techniques and optical imaging presented a wide application of intraoperative GU oncologic surgery. In most cases, image-guided surgery was shown to improve the surgical resectability of tumours. Conclusions Based on the evidence to date, image-guided surgery has promise in the near future for multiple GU malignancies. Further optimisation of targeted imaging agents, along with the integration of imaging modalities, is necessary to further enhance intraoperative GU oncologic surgery.",
keywords = "Augmented reality, Genitourinary oncologic surgery, Image-guided surgery, Molecular imaging, Surgical navigation",
author = "Francesco Greco and Cadeddu, {Jeffrey A} and Gill, {Inderbir S.} and Kaouk, {Jihad H.} and Mesut Remzi and Thompson, {R. Houston} and {Van Leeuwen}, {Fijs W B} and {Van Der Poel}, {Henk G.} and Paolo Fornara and Jens Rassweiler",
year = "2014",
doi = "10.1016/j.eururo.2013.07.033",
language = "English (US)",
volume = "65",
pages = "947--964",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers

AU - Greco, Francesco

AU - Cadeddu, Jeffrey A

AU - Gill, Inderbir S.

AU - Kaouk, Jihad H.

AU - Remzi, Mesut

AU - Thompson, R. Houston

AU - Van Leeuwen, Fijs W B

AU - Van Der Poel, Henk G.

AU - Fornara, Paolo

AU - Rassweiler, Jens

PY - 2014

Y1 - 2014

N2 - Context Molecular imaging (MI) entails the visualisation, characterisation, and measurement of biologic processes at the molecular and cellular levels in humans and other living systems. Translating this technology to interventions in real-time enables interventional MI/image-guided surgery, for example, by providing better detection of tumours and their dimensions. Objective To summarise and critically analyse the available evidence on image-guided surgery for genitourinary (GU) oncologic diseases. Evidence acquisition A comprehensive literature review was performed using PubMed and the Thomson Reuters Web of Science. In the free-text protocol, the following terms were applied: molecular imaging, genitourinary oncologic surgery, surgical navigation, image-guided surgery, and augmented reality. Review articles, editorials, commentaries, and letters to the editor were included if deemed to contain relevant information. We selected 79 articles according to the search strategy based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis criteria and the IDEAL method. Evidence synthesis MI techniques included optical imaging and fluorescent techniques, the augmented reality (AR) navigation system, magnetic resonance imaging spectroscopy, positron emission tomography, and single-photon emission computed tomography. Experimental studies on the AR navigation system were restricted to the detection and therapy of adrenal and renal malignancies and in the relatively infrequent cases of prostate cancer, whereas fluorescence techniques and optical imaging presented a wide application of intraoperative GU oncologic surgery. In most cases, image-guided surgery was shown to improve the surgical resectability of tumours. Conclusions Based on the evidence to date, image-guided surgery has promise in the near future for multiple GU malignancies. Further optimisation of targeted imaging agents, along with the integration of imaging modalities, is necessary to further enhance intraoperative GU oncologic surgery.

AB - Context Molecular imaging (MI) entails the visualisation, characterisation, and measurement of biologic processes at the molecular and cellular levels in humans and other living systems. Translating this technology to interventions in real-time enables interventional MI/image-guided surgery, for example, by providing better detection of tumours and their dimensions. Objective To summarise and critically analyse the available evidence on image-guided surgery for genitourinary (GU) oncologic diseases. Evidence acquisition A comprehensive literature review was performed using PubMed and the Thomson Reuters Web of Science. In the free-text protocol, the following terms were applied: molecular imaging, genitourinary oncologic surgery, surgical navigation, image-guided surgery, and augmented reality. Review articles, editorials, commentaries, and letters to the editor were included if deemed to contain relevant information. We selected 79 articles according to the search strategy based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis criteria and the IDEAL method. Evidence synthesis MI techniques included optical imaging and fluorescent techniques, the augmented reality (AR) navigation system, magnetic resonance imaging spectroscopy, positron emission tomography, and single-photon emission computed tomography. Experimental studies on the AR navigation system were restricted to the detection and therapy of adrenal and renal malignancies and in the relatively infrequent cases of prostate cancer, whereas fluorescence techniques and optical imaging presented a wide application of intraoperative GU oncologic surgery. In most cases, image-guided surgery was shown to improve the surgical resectability of tumours. Conclusions Based on the evidence to date, image-guided surgery has promise in the near future for multiple GU malignancies. Further optimisation of targeted imaging agents, along with the integration of imaging modalities, is necessary to further enhance intraoperative GU oncologic surgery.

KW - Augmented reality

KW - Genitourinary oncologic surgery

KW - Image-guided surgery

KW - Molecular imaging

KW - Surgical navigation

UR - http://www.scopus.com/inward/record.url?scp=84896335948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896335948&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2013.07.033

DO - 10.1016/j.eururo.2013.07.033

M3 - Article

C2 - 23957947

AN - SCOPUS:84896335948

VL - 65

SP - 947

EP - 964

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -